{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:19:00Z","timestamp":1790957940339,"version":"4.1.0"},"reference-count":89,"publisher":"Informa UK Limited","issue":"8","funder":[{"name":"clinical research for Anacor, Ascend Biopharmaceuticals, Astellas, Australian Wool Innovation Limited, Dermira, Genentech, GlaxoSmithKline and Trius"},{"name":"Abbott, Novartis and Janssen-Cilag"},{"name":"Anacor Pharmaceuticals, Inc."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.2217\/imt-2016-0023","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T12:04:37Z","timestamp":1465560277000},"page":"853-866","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":72,"title":["Crisaborole and its Potential Role in Treating Atopic Dermatitis: Overview of Early Clinical Studies"],"prefix":"10.1080","volume":"8","author":[{"given":"LT","family":"Zane","sequence":"first","affiliation":[{"name":"Anacor Pharmaceuticals,Inc., 1020 East Meadow Circle,\rPalo Alto,\rCA,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Chanda","sequence":"additional","affiliation":[{"name":"Anacor Pharmaceuticals,Inc., 1020 East Meadow Circle,\rPalo Alto,\rCA,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Jarnagin","sequence":"additional","affiliation":[{"name":"Anacor Pharmaceuticals,Inc., 1020 East Meadow Circle,\rPalo Alto,\rCA,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DB","family":"Nelson","sequence":"additional","affiliation":[{"name":"Anacor Pharmaceuticals,Inc., 1020 East Meadow Circle,\rPalo Alto,\rCA,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Spelman","sequence":"additional","affiliation":[{"name":"Veracity Clinical Research,\rQueensland,\rAustralia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LF Stein","family":"Gold","sequence":"additional","affiliation":[{"name":"Henry Ford Health System,\rDetroit,\rMI,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra074081"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2010.22.2.125"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-008-0049-z"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.03.023"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000370220"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/354250"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.03.045"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.10271"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04710.x"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2012.12.010"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00149-X"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12297888"},{"issue":"10","key":"e_1_3_2_15_1","first-page":"26","article-title":"The direct and indirect cost burden of atopic dermatitis. An employer-payer perspective","volume":"20","author":"Fowler JF","year":"2007","unstructured":"Fowler JF , DuhMS, RovbaLet al. The direct and indirect cost burden of atopic dermatitis. An employer-payer perspective. Manag. Care Interface20(10), 26\u201332 (2007).","journal-title":"Manag. Care Interface"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-013-0013-9"},{"issue":"2","key":"e_1_3_2_17_1","first-page":"157","article-title":"Atopic dermatitis. The itch that rashes","volume":"21","author":"Romeo SP.","year":"1995","unstructured":"Romeo SP. Atopic dermatitis. The itch that rashes. Pediatr. Nurs.21(2), 157\u2013163 (1995).","journal-title":"Pediatr. Nurs."},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2011.05.002"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-9-24"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.259"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2012.09.002"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(02)00368-1"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962005000300003"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12184"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.11.008"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01027.x"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.13-RAI-0564"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.01.053"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70535-X"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.11.006"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.12.1161"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(82)90008-2"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152807780077318"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.09.032"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70297-5"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.153.8.3408"},{"issue":"5","key":"e_1_3_2_37_1","first-page":"364","article-title":"Therapeutic benefit of PDE4 inhibitors in inflammatory diseases","volume":"8","author":"Dastidar SG","year":"2007","unstructured":"Dastidar SG , RajagopalD, RayA. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases. Curr. Opin. Investig. Drugs8(5), 364\u2013372 (2007).","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"2","key":"e_1_3_2_38_1","first-page":"753","article-title":"Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation","volume":"299","author":"Jimenez JL","year":"2001","unstructured":"Jimenez JL , PunzonC, NavarroJ, Munoz-FernandezMA, FresnoM. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation. J. Pharmacol. Exp. Ther.299(2), 753\u2013759 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.2.9708012"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(96)10039-0"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90013-5"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001829"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M307971200"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.092056"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.2.702-712.2000"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1062"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2010.11.018"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb08530.x"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1994.tb08532.x"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.03906.x"},{"key":"e_1_3_2_51_1","unstructured":"National Collaborating Centre for Women\u2018s and Children\u2018s Health (2007).www.ncc-wch.org.uk\/."},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb04195.x"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.70"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2005.22303.x"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1634"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-009-1744-y"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-011-0003-5"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1521\/suli.2006.36.1.120"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.530"},{"key":"e_1_3_2_60_1","article-title":"The relationship between suicidal behaviors and atopic dermatitis in Korean adolescents","author":"Noh HM","year":"2015","unstructured":"Noh HM , ChoJJ, ParkYS, KimJH. The relationship between suicidal behaviors and atopic dermatitis in Korean adolescents. J. Health Psychol.pii: 1359105315572453 (2015) (Epub ahead of print).","journal-title":"J. Health Psychol."},{"issue":"2","key":"e_1_3_2_61_1","first-page":"211","article-title":"Gender differences in depression and anxiety among atopic dermatitis patients","volume":"60","author":"Mina S","year":"2015","unstructured":"Mina S , JabeenM, SinghS, VermaR. Gender differences in depression and anxiety among atopic dermatitis patients. Indian J. Dermatol.60(2), 211 (2015).","journal-title":"Indian J. Dermatol."},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2011.11.006"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01047.x"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04711.x"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.09.033"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.12.672"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-013-0371-y"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07538.x"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.97655"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700622"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1586\/17469872.2.1.31"},{"key":"e_1_3_2_72_1","first-page":"7","article-title":"Topical corticosteroids. Mechanisms of action","volume":"151","author":"Kragballe K.","year":"1989","unstructured":"Kragballe K. Topical corticosteroids. Mechanisms of action. Acta Derm. Venereol.151, 7\u201310 (1989).","journal-title":"Acta Derm. Venereol."},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1980.01640310056019"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.11.024"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2010.00636.x"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.02.028"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.4305"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12331"},{"key":"e_1_3_2_79_1","unstructured":"Compound Summary for CID 44591583 . PubChem Open Chemistry Database 906673\u201324\u20133 (2015). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/906673-24-3."},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.03.007"},{"issue":"11","key":"e_1_3_2_81_1","first-page":"1236","article-title":"AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis","volume":"10","author":"Nazarian R","year":"2009","unstructured":"Nazarian R , WeinbergJM. AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis. Curr. Opin. Investig. Drugs10(11), 1236\u20131242 (2009).","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2012.07.058"},{"issue":"4","key":"e_1_3_2_83_1","first-page":"390","article-title":"Crisaborole topical ointment, 2%. a nonsteroidal, topical, anti-inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis","volume":"15","author":"Jarnagin K","year":"2016","unstructured":"Jarnagin K , ChandaS, CoronadoDet al. Crisaborole topical ointment, 2%. a nonsteroidal, topical, anti-inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis. J. Drugs Dermatol.15(4), 390\u2013396 (2016).","journal-title":"J. Drugs Dermatol."},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12872"},{"issue":"10","key":"e_1_3_2_85_1","first-page":"19","article-title":"Crisaborole topical ointment, 2% in adults with atopic dermatitis. A Phase 2A, vehicle-controlled, proof-of-concept study","volume":"14","author":"Murrell D","year":"2015","unstructured":"Murrell D , GebauerK, SpelmanL, ZaneLT. Crisaborole topical ointment, 2% in adults with atopic dermatitis. A Phase 2A, vehicle-controlled, proof-of-concept study. J. Drugs Dermatol.14(10), 19\u201323 (2015).","journal-title":"J. Drugs Dermatol."},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.12780"},{"issue":"12","key":"e_1_3_2_87_1","first-page":"1394","article-title":"A phase 2, randomized, controlled, dose-ranging study evaluating crisaborole topical ointment, 0.5% and 2% in adolescents with mild to moderate atopic dermatitis","volume":"14","author":"Stein Gold LF","year":"2015","unstructured":"Stein Gold LF , SpelmanL, SpellmanMC, HughesMH, ZaneLT. A phase 2, randomized, controlled, dose-ranging study evaluating crisaborole topical ointment, 0.5% and 2% in adolescents with mild to moderate atopic dermatitis. J. Drugs Dermatol.14(12), 1394\u20131399 (2015).","journal-title":"J. Drugs Dermatol."},{"key":"e_1_3_2_88_1","volume-title":"18th North American Regional ISSX","author":"Liu L","year":"2012","unstructured":"Liu L , MusickTJ, LuoGet al. In vitro and in vivo investigation on metabolic fate of AN2728, a novel boron based small molecules for treatment of psoriasis and atopic dermatitis. Presented at: 18th North American Regional ISSX. Dallas, TX, USA, 14\u201318October2012."},{"issue":"2","key":"e_1_3_2_89_1","first-page":"172","article-title":"Post hoc analyses of the effect of crisaborole topical ointment, 2% on atopic dermatitis. associated pruritus from Phase 1 and 2 clinical studies","volume":"15","author":"Draelos ZD","year":"2016","unstructured":"Draelos ZD , Stein GoldLF, MurrellDF, HughesMH, ZaneLT. Post hoc analyses of the effect of crisaborole topical ointment, 2% on atopic dermatitis. associated pruritus from Phase 1 and 2 clinical studies. J. Drugs Dermatol.15(2), 172\u2013176 (2016).","journal-title":"J. Drugs Dermatol."},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.5070\/D3205022608"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-013-0023-0"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2016-0023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:11:26Z","timestamp":1715980286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2016-0023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.2217\/imt-2016-0023"],"URL":"https:\/\/doi.org\/10.2217\/imt-2016-0023","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-02-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-06-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}